ArticleEuropean heart journal. Case reports2026
Cardiac sarcoidosis imaging features and latest advances in the management of arrhythmias: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiac sarcoidosis (CS) is a potentially life-threatening granulomatous inflammatory cardiomyopathy associated with conduction abnormalities, ventricular arrhythmias, and heart failure. Multimodality imaging plays a key role in diagnosis, risk stratification, and guiding therapy. Case summary: A 53-year-old male presented with an out-of-hospital ventricular fibrillation arrest in May 2022. Transthoracic echocardiography demonstrated moderate left ventricular (LV) systolic impairment with hypokinesis of the basal inferoseptum, anteroseptal, and basal to mid-inferior walls. Invasive coronary angiography excluded flow-limiting coronary artery disease, and a cardiac resynchronization therapy defibrillator was implanted.Cardiac magnetic resonance imaging (CMR) was performed in February 2024, but image quality was suboptimal due to device artefact. It showed generalized hypokinesia with thinning and akinesia of the basal to mid-septum; late gadolinium enhancement was present but difficult to characterize. Over the following 18 months, serial CMR and Discussion: This case highlights the role of CMR and PET in monitoring CS, differentiating inflammatory from scar-mediated arrhythmias and guiding advanced interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.